azacitidine has been researched along with Exanthema in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, M; Iwasaki, M; Kanda, J; Kataoka, A; Mizumoto, C; Nannya, Y; Ogawa, S; Oka, T; Sakurada, M; Takaori-Kondo, A; Yamamoto, Y; Yamashita, K | 1 |
| Almeida, A; Esteves, S; Pierdomenico, F | 1 |
| Kotoula, V; Papaioannou, M; Sapalidis, K | 1 |
| Bauman, J; Belinsky, S; Fekrazad, M; Jones, D; Lee, SJ; Muller, C; Ravindranathan, M; Rutledge, T; Verschraegen, C | 1 |
| Almeida, AM; Pierdomenico, F | 1 |
1 trial(s) available for azacitidine and Exanthema
| Article | Year |
|---|---|
A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cohort Studies; Conjunctivitis; Diarrhea; Disease-Free Survival; Erlotinib Hydrochloride; Exanthema; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Quinazolines; Treatment Outcome | 2012 |
4 other study(ies) available for azacitidine and Exanthema
| Article | Year |
|---|---|
Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
Topics: Aged; Azacitidine; Enzyme Inhibitors; Exanthema; Fever; Humans; Inflammation; Male; Mutation; Myelodysplastic Syndromes | 2023 |
Efficacy and tolerability of 5-day azacytidine dose-intensified regimen in higher-risk MDS.
Topics: Adult; Aged; Azacitidine; Cohort Studies; Drug Administration Schedule; Exanthema; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Risk Factors; Survival Rate; Treatment Outcome | 2013 |
Alleviation of myelodysplastic syndrome-associated skin rush after treatment with decitabine.
Topics: Aged; Anemia, Refractory; Antimetabolites, Antineoplastic; Azacitidine; Blood Transfusion; Chromosome Deletion; Chromosomes, Human, Y; Decitabine; Exanthema; Humans; Male | 2008 |
Generalized skin reactions in patients with MDS and CMML treated with azacitidine: Effective management with concomitant prednisolone.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Exanthema; Female; Humans; Leukemia, Myelomonocytic, Chronic; Male; Myelodysplastic Syndromes; Prednisolone; Treatment Outcome | 2012 |